November 09, 2021
Fusion Pharmaceuticals Announces Third Quarter 2021 Financial Results And Clinical Program Update
Media
November 09, 2021
Targovax announces two posters at the 2021 Society for Immunotherapy of Cancer (SITC) Annual Meeting
November 08, 2021
Aprea Therapeutics Reports Third Quarter 2021 Financial Results and Provides Update on Business Operations
November 08, 2021
Nordic Nanovector appoints experienced biotech executive Pierre Dodion MD as Chief Medical Officer
November 04, 2021
Aprea Therapeutics to Present Data from Clinical Trials Evaluating Eprenetapopt at 63rd American Society of Hematology Annual Meeting
November 04, 2021
Oncopeptides focuses clinical development efforts to increase cash runway
November 04, 2021
BONESUPPORT Holding AB (publ) – Publishes Q3 2021 Interim report
November 04, 2021
Targovax ASA: Third quarter 2021 results
November 04, 2021
Interim report July – September 2021
November 02, 2021
Fusion Pharmaceuticals Appoints Industry Veteran Christopher Leamon, Ph.D., As Chief Scientific Officer